The full schedule of the Nucleic Acids and Nanobiosystems in Cancer Theranostics event is now available.
The event lasts 4 days, from October 16 to 19, and takes place at the Auditorium of the Instituto do Câncer do Estado de São Paulo (ICESP).
Tickets can be purchased through the Sympla platform.
In an interview with C2PO, Dr. Luciana Barros, lead researcher of the study, explains how BreastOncoPredict was developed, the findings that surprised the researchers, and the next steps to validate the tool in other SUS hospitals.
The Folha de S. Paulo and Icesp Award recognized studies on acute myeloid leukemia and drug delivery to the brain, as well as the career of Prof. Dr. Luisa Lina Villa, who helped establish the link between HPV and cancer.
Researchers are finalists in the Oncology Research and Technological Innovation in Oncology categories. Organized by the Icesp and Folha de S. Paulo, the award ceremony will take place on August 12, 2026.
Software developed by USP and Icesp researchers uses routine blood test data to predict breast cancer recurrence risk, with the potential to expand access to prognostic assessment in Brazil’s public healthcare system